AEON Biopharma (AEON) EPS (Basic) Growth (1y) (2022 - 2026)
AEON Biopharma (AEON) EPS (Basic) Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 88.81% |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 7.59% |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 143.95% |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 322.67% |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | -147.33% |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 96.41% |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | -16.29% |
| 10 | AEON Biopharma | 9.39 Mn | 5.96 Mn | - | 96.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 80.56% |
| Dec 31, 2025 | -178.45% |
| Sep 30, 2025 | 96.53% |
| Jun 30, 2025 | -100.20% |
| Mar 31, 2025 | 101.00% |
| Sep 30, 2024 | 98.05% |
| Jun 30, 2024 | 3,387.71% |
| Mar 31, 2024 | -16,197.32% |
| Sep 30, 2023 | -67,414.40% |
| Jun 30, 2023 | -337.45% |
| Mar 31, 2023 | -124.17% |
| Dec 31, 2022 | -99.64% |
| Sep 30, 2022 | -92.74% |
| Jun 30, 2022 | 111.60% |
| Mar 31, 2022 | -71.68% |